BDX 250117 225.00P (BDX250117P225000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

BDX250117P225000

Watchlist

1.55
-0.55-26.19%

15min DelayClose Jan 3 16:00 ET

1.57High1.55Low

Intraday

5D
Daily

News

Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Kevin TraversJan 3 16:19 ET
Friday? More Like Grinch Day | Wall Street Today
Kevin TraversJan 3 16:02 ET
Santa Claus Came Without Rallying the Troops | Live Stock
Kevin TraversJan 3 10:45 ET
Today's Analyst Rating | ServiceNow Price Target Raised to $1210 by RBC Capital, Goldman Sachs Price Target Raised to $623 by Evercore
Moomoo NewsJan 3 08:00 ET · Ratings
Evercore Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $275
Moomoo NewsJan 2 07:32 ET · Ratings
BDX Vs. MMSI: Which Stock Is the Better Value Option?
Zacks Jan 1 11:00 ET

Comments

103208831

Apr 18, 2024 11:43

$Becton Dickinson & Co (BDX.US)$ GAME OVER stock.

Moomoo AI

Feb 29, 2024 06:14

Despite a dip in earnings, Becton Dickinson's high P/E ratio persists due to anticipated robust future growth, outpacing the broader market. Investors' confidence in the company's future earnings is high, indicating the share price is unlikely to drop significantly soon.

Earnings Tell The Story For Becton, Dickinson and Company (NYSE:BDX)

Alvinnnnnnngenius

Dec 7, 2023 05:54

Big news

$Becton Dickinson & Co (BDX.US)$ BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device

Moomoo AI

Nov 21, 2023 05:52

Dr. Silverman's extensive experience and zeal for innovation, evidence generation, clinical development, medical safety, and compliance is predicted to boost BD's innovation pipeline and foster improved, personalized care.

Press Release: BD Names Dr. Ronald Silverman as Chief Medical Officer

Moomoo AI

Oct 10, 2023 11:30

Market sentiment towards Becton, Dickinson and Company shows no major shift in the past year. However, the rise in total shareholder return hints at a growing positivity.

Investing in Becton Dickinson (NYSE:BDX) a Year Ago Would Have Delivered You a 15% Gain